Veralox Therapeutics Company
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.
%20University%20System%20of%20Maryland.png)
%20Innovation%20Fund.png)
Total Funding:
22000000.0
Headquarters:
Frederick, Maryland, United States
Funding Status:
Early Stage Venture
Employee Number:
1-10
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Last Funding Date:
2021-06-16
Investors Number:
13.0
Founded Date:
2017-01-01
Industry:
Early Drug Development